首页> 外文OA文献 >HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER

【2h】

HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER

机译：HDAC靶向药物的纳米药物治疗可提高三联阴性乳腺癌中帕西他赛的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
LIM CHEN SIEW;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. A multicenter phase II study evaluating the efficacy of nivolumab plus paclitaxel plus bevacizumab triple-combination therapy as a first-line treatment in patients with HER2-negative metastatic breast cancer: WJOG9917B NEWBEAT trial [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：多中心期II研究评估Nivolumab Plus Paclitaxel Plus Bevacizumab三重组合疗法作为Her2阴性转移乳腺癌患者的一线治疗的疗效：WJOG9917B Newbeat试验
2. The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype. [J] . Aogi K, Yoshida M, Sagara Y, Cancer chemotherapy and pharmacology. . 2011,第5期

机译：吉西他滨联合紫杉醇联合一线治疗对包括三阴性表型在内的日本转移性乳腺癌患者的疗效和安全性。
3. The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype [J] . Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Cancer Chemotherapy and Pharmacology . 2011,第5期

机译：吉西他滨联合紫杉醇联合一线治疗日本转移性乳腺癌三阴性表型的疗效和安全性
4. Optical coherence elastography as a new method for estimation of chemotherapy efficacy on triple-negative breast cancer in the experiment [C] . Anton A. Plekhanov, Marina A. Sirotkina, Alexander A. Sovetsky, International Symposium on Optics and Biophotonics: Saratov Fall Meeting . 2019

机译：光学相干弹性造影作为对实验中三阴性乳腺癌化疗疗效估算的新方法
5. Metronomic Chemotherapy and Immunotherapy for Triple Negative Breast Cancer [D] . Lopez, Candice. 2020

机译：用于三重阴性乳腺癌的度量组化疗和免疫疗法
6. Enhanced Paclitaxel Efficacy to Suppress Triple-Negative Breast Cancer Progression Using Metronomic Chemotherapy with a Controlled Release System of Electrospun Poly-d-l-Lactide-Co-Glycolide (PLGA) Nanofibers [O] . Ming-Yi Hsu, Cheng-Hsien Hsieh, Yu-Ting Huang, 2021

机译：增强紫杉醇的疗效抑制了使用富纺聚-1-丙交酯 - 共乙酰基（PLGA）纳米纤维的控制释放系统的衡量化疗抑制了三阴性乳腺癌进展
7. EVALUATION OF EFFICACY AND TOXICITY OF NEOADJUVANT CHEMOTHERAPY WITH DOSE-DENSE DOXORUBICIN, CISPLATIN, AND PACLITAXEL IN PATIENTS WITH EARLY TRIPLE-NEGATIVE BREAST CANCER [O] . E. O. Ignatova, M. A. Frolova, A. B. Petrovsky, 2016

机译：患有剂量 - 致密的多柔比星，顺铂和紫杉醇患者早期三阴性乳腺癌患者的疗效和毒性评价

HDAC INHIBITOR-TARGETED THERAPY WITH NANOMEDICINE INCREASES THE EFFICACY OF PACLITAXEL IN TRIPLE NEGATIVE BREAST CANCER

著录项

引文网络

相似文献

相关主题

期刊订阅